Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 14, 2016 –The FDA announced the approval of Pfizer’s Eucrisa (crisaborole) ointment, for topical treatment of mild to moderate atopic dermatitis (AD) in patients 2 years of age and older.
Return to publications